{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:46:36Z","timestamp":1762004796763},"reference-count":34,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Mucopolysaccharidosis type IIIB (MPS IIIB) is a rare genetic disorder in which the deficiency of the lysosomal enzyme <jats:italic>N<\/jats:italic>\u2010acetyl\u2010\u03b1\u2010glucosaminidase (NAGLU) results in the accumulation of heparan sulfate (HS), leading to progressive neurocognitive deterioration. In MPS IIIB a wide spectrum of disease severity is seen. Due to a large allelic heterogeneity, establishing genotype\u2010phenotype correlations is difficult. However, reliable prediction of the natural course of the disease is needed, in particular for the assessment of the efficacy of potential therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To identify markers that correlate with disease severity, all Dutch patients diagnosed with MPS IIIB were characterised as either rapid (RP; classical, severe phenotype) or slow progressors (SP; non\u2010classical, less severe phenotype), based on clinical data. NAGLU activity and HS levels were measured in patients\u2019 fibroblasts after culturing at different temperatures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A small, though significant difference in NAGLU activity was measured between RP and SP patients after culturing at 37 \u00b0C (p\u2009&lt;\u20090.01). Culturing at 30 \u00b0C resulted in more pronounced and significantly higher NAGLU activity levels in SP patients (p\u2009&lt;\u20090.001) with a NAGLU activity of 0.58 nmol.mg\u20101.hr\u20101 calculated to be the optimal cut\u2010off value to distinguish between the groups (sensitivity and specificity 100 %). A lower capacity of patients\u2019 fibroblasts to increase NAGLU activity at 30 \u00b0C could significantly predict for the loss of several disease specific functions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NAGLU activity in fibroblasts cultured at 30 \u00b0C can be used to discriminate between RP and SP MPS IIIB patients and the capacity of cells to increase NAGLU activity at lower temperatures correlates with disease symptoms.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s10545-016-9916-2","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T09:23:57Z","timestamp":1456219437000},"page":"437-445","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Residual <i>N<\/i>\u2010acetyl\u2010\u03b1\u2010glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB"],"prefix":"10.1002","volume":"39","author":[{"given":"O. L. M.","family":"Meijer","sequence":"first","affiliation":[{"name":"Department of Pediatric Metabolic Diseases, Emma Children's Hospital and Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center University of Amsterdam Meibergdreef 9 Amsterdam 1105 AZ The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Welling","sequence":"additional","affiliation":[{"name":"Department of Pediatric Metabolic Diseases, Emma Children's Hospital and Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center University of Amsterdam Meibergdreef 9 Amsterdam 1105 AZ The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Valstar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Metabolic Diseases, Emma Children's Hospital and Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center University of Amsterdam Meibergdreef 9 Amsterdam 1105 AZ The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. H.","family":"Hoefsloot","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics Erasmus University Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. T.","family":"Br\u00fcggenwirth","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics Erasmus University Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. T.","family":"van der Ploeg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Lysosomal and Metabolic Diseases Erasmus University Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. J. G.","family":"Ruijter","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics Erasmus University Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Wagemans","sequence":"additional","affiliation":[{"name":"Laboratory Genetic Metabolic Diseases, Academic Medical Center University of Amsterdam Meibergdreef 9 Amsterdam 1105 AZ The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. A.","family":"Wijburg","sequence":"additional","affiliation":[{"name":"Department of Pediatric Metabolic Diseases, Emma Children's Hospital and Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center University of Amsterdam Meibergdreef 9 Amsterdam 1105 AZ The Netherlands"},{"name":"Department of Pediatric Metabolic Diseases, Emma Children's Hospital and Amsterdam Lysosome Center \u2018Sphinx\u2019 (H7\u2010270), Academic Medical Center University of Amsterdam Meibergdreef 9 Amsterdam 1105 AZ The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"van Vlies","sequence":"additional","affiliation":[{"name":"Department of Pediatric Metabolic Diseases, Emma Children's Hospital and Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center University of Amsterdam Meibergdreef 9 Amsterdam 1105 AZ The Netherlands"},{"name":"Laboratory Genetic Metabolic Diseases, Academic Medical Center University of Amsterdam Meibergdreef 9 Amsterdam 1105 AZ The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,2,23]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-0112-z"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.35.11.910"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0009-9163.2004.00210.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-0093-y"},{"key":"e_1_2_9_6_1","first-page":"28","article-title":"Mucopolysaccharidosis type IIIB (Sanfilippo B): identification of 18 novel \u03b1\u2010N\u2010acetylglucosaminidase gene mutations","volume":"36","author":"Bunge S","year":"1999","journal-title":"J Med Genet"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2010.01.004"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-005-0258-4"},{"key":"e_1_2_9_9_1","unstructured":"DiekmanEFFerdinandusseSvan derPolLetalFatty acid oxidation flux predicts the clinical severity of VLCAD deficiencyGenet Med2015."},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9009"},{"key":"e_1_2_9_11_1","volume-title":"Essentials of glycobiology","author":"Esko JD","year":"2009"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(99)00118-0"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20062"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.25.3115"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-99"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.06.013"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014192"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1985.tb00217.x"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1517\/21678707.2013.830069"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30142"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker394"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2011.08.032"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004399900075"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/301685"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2011.126"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2013.01.009"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004390000429"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0838-5"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9199-y"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22092"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1976.tb00049.x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200242"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.12.6101"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1086\/301682"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10545-016-9916-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10545-016-9916-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-016-9916-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10545-016-9916-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T03:52:41Z","timestamp":1694749961000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-016-9916-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1007\/s10545-016-9916-2"],"URL":"https:\/\/doi.org\/10.1007\/s10545-016-9916-2","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]}}}